Pramipexole in the management of restless legs syndrome: An extended study

Sleep

Volumn 26, Issue 7, 2003, Pages 819-821

  Silber, Michael H ^a   Girish, Mirle ^a   Izurieta, Ricardo ^a  

^a MAYO CLINIC   (United States)

Author keywords

Augmentation; Pramipexole; Restless legs syndrome

Indexed keywords

PRAMIPEXOLE; BENZOTHIAZOLE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; PRAMIPEXOL; THIAZOLE DERIVATIVE;

ADULT; AGED; DIZZINESS; DOSE RESPONSE; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; FOLLOW UP; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NAUSEA; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; RETROSPECTIVE STUDY; REVIEW; SIDE EFFECT; ARTICLE; CLINICAL TRIAL; DRUG ADMINISTRATION; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; BENZOTHIAZOLES; DOPAMINE AGONISTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RESTLESS LEGS SYNDROME; RETROSPECTIVE STUDIES; THIAZOLES;

EID: 2142762707     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/26.7.819     Document Type: Review

References (18)

1. Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group Mov Disord 1995;10:634-42
2. Phillips B, Young T, Finn L, et al. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000;160:2137-41.
3. Hening W, Allen R, Earley C, et al The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Review. Sleep 1999;22:970-99.
4. Allen RP, Earley CJ. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 1996;19:205-13.
5. Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology 1999;52:938-43.
6. Wetter TC, Stiasny K, Winkelmann J, et al. A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 1999;52:944-50.
7. Earley CJ, Yaffee JB, Allen RP. Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome. Neurology 1998;51:1599-602.
8. Penzel T, Brandenburg U, Peter JH, et al. A new design of a polysomnography-based multi-center treatment study for the restless legs syndrome. Clin Neurophysiol 2002;113:571-8
9. Staedt J, Wassmuth F, Ziemann U, et al. Pergolide: treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double-blind randomized crossover trial of pergolide versus L-Dopa. J Neural Transm 1997;104:461-8.
10. Silber MH, Shepard JW, Jr, Wisbey JA. Pergolide in the management of restless legs syndrome: an extended study. Sleep 1997;20:878-82
11. Stiasny K, Moller JC, Oertel WH. Safety of pramipexole in patients with restless legs syndrome. Neurology 2000;55:1589-90.
12. Stiasny K, Wetter TC, Winkelmann J, et al. Long-term effects of pergolide in the treatment of restless legs syndrome. Neurology 2001;56:1399-402.
13. Montplaisir J, Denesle R, Petit D. Pramipexole in the treatment of restless legs syndrome: a follow-up study Eur J Neurol 2000;7:27-31.
14. Earley CJ, Allen RP. Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients. Sleep 1996;19:801-10.
15. Parkinson Study Group. Satety and efficacy of pramipexole in early Parkinson disease. A randomized dose-ranging study. JAMA 1997;278:125-30
16. Wright CE, Sisson TL, Ichhpurani AK, Peters GR. Steady-state pharmacokinetic properties of pramipexole in healthy volunteers. J Clin Pharmacol 1997;37:520-5.
17. Ferini-Strambi L. Restless legs syndrome augmentation and pramipexole treatment. Sleep Med 2002;3:S23-5.
18. Parkinson Study Group Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group. JAMA 2000;284:1931-8.